Darstellung eines Auges auf der linken Bildhälfte und auf der rechten MRT-Schnitt eines Auges mit Augentumor und Isodosen.
Bild: BerlinProtonen, Charité

BerlinProtonen: proton therapy of eye tumors at the Charité

BerlinProtonen stands for the proton therapy of eye tumors and eye cancer at the Charité - Universitätsmedizin Berlin. The proton irradiations are carried out in close cooperation with the Helmholtz-Zentrum Berlin für Materialien und Energie (HZB) at the proton accelerator facility in Berlin-Wannsee.
Proton therapy for choroidal, iris and ciliary body melanoma has been used in Berlin since 1998. The treatment of intraocular tumors has become a true success story. The systematic collaboration of medical physicists, radiation therapists and ophthalmologists has improved the precision of the therapy for the well-being of the afflicted patients. Today, eye cancer can be controlled in 96% of the patients. In the majority of large tumors, not only the affected eye but also a useful function is preserved.

Interdisciplinary cooperation in the treatment of eye tumors

The Tumor Outpatient Clinic of the Department of Ophthalmology in cooperation with the Department of Radiation Oncology and Radiotherapy, the Helmholtz-Zentrum Berlin and the Charité Comprehensive Cancer Center (CCCC) ensures an interdisciplinary, guideline-based diagnostics and therapy of tumor patients based on state-of-the-art findings. Patients receive the best possible treatment and care through:

  • interdisciplinary cooperation of the different disciplines at the Charité
  • Joint research of the partners in the areas of tumor therapy and follow-up care